These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 27507060)
21. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models. Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535 [TBL] [Abstract][Full Text] [Related]
22. The Inhibitory Effect of Abietic Acid on Melanoma Cancer Metastasis and Invasiveness In Vitro and In Vivo. Hsieh YS; Yang SF; Hsieh YH; Hung CH; Chu SC; Yang SH; Chen PN Am J Chin Med; 2015; 43(8):1697-714. PubMed ID: 26621449 [TBL] [Abstract][Full Text] [Related]
23. p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma. Sauter ER; Takemoto R; Litwin S; Herlyn M Cancer Gene Ther; 2002 Oct; 9(10):807-12. PubMed ID: 12224020 [TBL] [Abstract][Full Text] [Related]
24. Myrtenal-induced V-ATPase inhibition - A toxicity mechanism behind tumor cell death and suppressed migration and invasion in melanoma. Martins BX; Arruda RF; Costa GA; Jerdy H; de Souza SB; Santos JM; de Freitas WR; Kanashiro MM; de Carvalho ECQ; Sant'Anna NF; Antunes F; Martinez-Zaguilan R; Souad S; Okorokova-Façanha AL; Façanha AR Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):1-12. PubMed ID: 30279148 [TBL] [Abstract][Full Text] [Related]
25. Dehydroleucodine inhibits tumor growth in a preclinical melanoma model by inducing cell cycle arrest, senescence and apoptosis. Costantino VV; Lobos-Gonzalez L; Ibañez J; Fernandez D; Cuello-Carrión FD; Valenzuela MA; Barbieri MA; Semino SN; Jahn GA; Quest AF; Lopez LA Cancer Lett; 2016 Mar; 372(1):10-23. PubMed ID: 26718258 [TBL] [Abstract][Full Text] [Related]
26. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice. Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406 [TBL] [Abstract][Full Text] [Related]
28. Antitumor activity of small double-stranded oligodeoxynucleotides targeting telomerase RNA in malignant melanoma cells. Noreen F; Heinrich J; Moelling K Oligonucleotides; 2009 Jun; 19(2):169-78. PubMed ID: 19441892 [TBL] [Abstract][Full Text] [Related]
29. Icariside II induces apoptosis of melanoma cells through the downregulation of survival pathways. Wu J; Xu J; Eksioglu EA; Chen X; Zhou J; Fortenbery N; Wei S; Dong J Nutr Cancer; 2013; 65(1):110-7. PubMed ID: 23368920 [TBL] [Abstract][Full Text] [Related]
30. NFAT5 promotes in vivo development of murine melanoma metastasis. Kim DH; Kim KS; Ramakrishna S Biochem Biophys Res Commun; 2018 Nov; 505(3):748-754. PubMed ID: 30293684 [TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo effect of IFNalpha on B16F10 melanoma in two models: subcutaneous (C57BL6J mice) and lung metastasis (Swiss mice). Martínez Conesa C; Alvarez Sánchez N; Vicente Ortega V; García Reverte J; Pascual Carpe F; Campos Aranda M Biomed Pharmacother; 2009 May; 63(4):305-12. PubMed ID: 19171452 [TBL] [Abstract][Full Text] [Related]
32. Regression of melanoma in a murine model by RLIP76 depletion. Singhal SS; Awasthi YC; Awasthi S Cancer Res; 2006 Feb; 66(4):2354-60. PubMed ID: 16489041 [TBL] [Abstract][Full Text] [Related]
33. Combination therapy with BH3 mimetic and hyperthermia tends to be more effective on anti-melanoma treatment. Shi Z; Lan B; Peng B; Wang X; Zhang G; Li X; Guo F Biochem Biophys Res Commun; 2018 Sep; 503(1):249-256. PubMed ID: 29885833 [TBL] [Abstract][Full Text] [Related]
34. RNA interference of metastasis-associated gene 1 inhibits metastasis of B16F10 melanoma cells in a C57BL/6 mouse model. Qian H; Yu J; Li Y; Wang H; Song C; Zhang X; Liang X; Fu M; Lin C Biol Cell; 2007 Oct; 99(10):573-81. PubMed ID: 17868030 [TBL] [Abstract][Full Text] [Related]
35. Antisense-mediated melanoma inhibitor of apoptosis protein downregulation sensitizes G361 melanoma cells to cisplatin. Mousavi-Shafaei P; Ziaee AA; Azizi E; Zangemeister-Wittke U Anticancer Drugs; 2006 Oct; 17(9):1031-9. PubMed ID: 17001176 [TBL] [Abstract][Full Text] [Related]
36. Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model. Lee CH; Wu CL; Shiau AL Cancer Gene Ther; 2005 Feb; 12(2):175-84. PubMed ID: 15375381 [TBL] [Abstract][Full Text] [Related]
37. Long exposure of non-cytotoxic concentrations of methylselenol suppresses the invasive potential of B16F10 melanoma. Kim A; Jung JY; Son M; Lee SH; Lim JS; Chung AS Oncol Rep; 2008 Sep; 20(3):557-65. PubMed ID: 18695906 [TBL] [Abstract][Full Text] [Related]
38. Sequential chemoimmunotherapy with cisplatin, interferon-beta and interleukin-2 inhibits the growth of B16-F1 melanoma in syngeneic mice. Kubo H; Matsumoto K; Funahashi M; Takagi H; Kitajima Y; Taniguchi S; Saida T Melanoma Res; 2000 Jun; 10(3):223-9. PubMed ID: 10890375 [TBL] [Abstract][Full Text] [Related]
39. Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model. Thallinger C; Wolschek MF; Wacheck V; Maierhofer H; Günsberg P; Polterauer P; Pehamberger H; Monia BP; Selzer E; Wolff K; Jansen B J Invest Dermatol; 2003 Jun; 120(6):1081-6. PubMed ID: 12787138 [TBL] [Abstract][Full Text] [Related]
40. Citrus unshiu peel suppress the metastatic potential of murine melanoma B16F10 cells in vitro and in vivo. Choi EO; Lee H; HwangBo H; Kwon DH; Kim MY; Ji SY; Hong SH; Kim GY; Park C; Hwang HJ; Moon SK; Yun SJ; Kim WJ; Choi YH Phytother Res; 2019 Dec; 33(12):3228-3241. PubMed ID: 31486124 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]